HDAC9 and osteosarcoma: Investigations of HDAC inhibitors in canine osteosarcoma cells have proposed perturbations in the oxidative phosphorylation, cytoskeleton remodeling, cell cycle, and ubiquitin-proteasome pathways by gene expression analysis34.